Production (Stage)
Avidity Biosciences, Inc.
RNA
$30.58
-$0.23-0.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.38B | 1.50B | 1.59B | 1.30B | 915.87M |
| Total Receivables | 36.58M | 28.22M | 19.21M | 15.71M | 9.04M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 18.52M | 12.57M | 14.06M | 14.04M | 9.56M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.43B | 1.54B | 1.62B | 1.33B | 934.47M |
|
|
|||||
| Total Current Assets | 1.43B | 1.54B | 1.62B | 1.33B | 934.47M |
| Net Property, Plant & Equipment | 20.57M | 18.29M | 15.79M | 15.47M | 16.28M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.53M | 3.32M | 3.11M | 3.16M | 720.00K |
| Total Assets | 1.46B | 1.56B | 1.64B | 1.35B | 951.47M |
|
|
|||||
| Total Accounts Payable | 6.63M | 8.46M | 7.66M | 8.89M | 2.35M |
| Total Accrued Expenses | 60.37M | 64.73M | 60.21M | 44.86M | 42.78M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.88M | 3.84M | 3.80M | 3.77M | 3.73M |
| Total Finance Division Other Current Liabilities | 13.98M | 20.99M | 19.66M | 26.70M | 26.10M |
| Total Other Current Liabilities | 13.98M | 20.99M | 19.66M | 26.70M | 26.10M |
| Total Current Liabilities | 84.87M | 98.02M | 91.33M | 84.21M | 74.96M |
|
|
|||||
| Total Current Liabilities | 84.87M | 98.02M | 91.33M | 84.21M | 74.96M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.09M | 2.96M | 3.80M | 4.62M | 5.42M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 43.40M | 37.96M | 42.26M | 37.56M | 40.20M |
| Total Liabilities | 130.35M | 138.94M | 137.39M | 126.39M | 120.58M |
|
|
|||||
| Common Stock & APIC | 2.33B | 2.32B | 2.29B | 1.93B | 1.47B |
| Retained Earnings | -1.01B | -893.07M | -790.81M | -710.41M | -639.62M |
| Treasury Stock & Other | 2.77M | 2.90M | 7.10M | -453.00K | -464.00K |
| Total Common Equity | 1.33B | 1.42B | 1.50B | 1.22B | 830.90M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.33B | 1.42B | 1.50B | 1.22B | 830.90M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.33B | 1.42B | 1.50B | 1.22B | 830.90M |
|
|
|||||